Researcher Profile
Kim, Bo Kyung(김보경)
83
Genomic Medicine Research Center (유전체맞춤의학연구센터)
- Tel042-879-8177
- Technology
- Research Keywords
- Cancer ; Gene regulation ; Target discovery and verification
- 암 ; 유전자 발현 조절 ; 타겟 발굴/검증
Keywords Cloud
KRIBB Co-Working
Results 1-20 of 83 (Search time: 0.002 seconds).
| No. | Year | Title | Type |
|---|---|---|---|
| 83 | 2025 | 2025Article Anti-proteolytic regulation of KRAS by USP9X/NDRG3 in KRAS-driven cancer developmentNature Communications, vol. 16, pp. 628-628Han Koo; Kyung Chan Park; Hyun Ahm Sohn; Minho Kang; D J Kim; Z Y Park; S Park; S H Min; Seong-Hwan Park; Yeon Mi You, et al. |
Article |
| 82 | 2025 | 2025Article VHL-mediated SYT11 degradation suppresses gastric cancer cell growth and invasion through downregulation of SPINK1Journal of Cellular and Molecular Medicine, vol. 29, no. 13, pp. e70658-e70658Ji Su Yu; Mi Aie Hwang; Mi Sun Won; Joo-Young Im; D H Kweon; Y G Park; Bo Kyung Kim |
Article |
| 81 | 2025 | 2025Research Project 바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 김선영 / 사업기간 : 2025.01.01 ~ 2025.12.31 |
Research Project |
| 80 | 2025 | 2025Research Project 미만형 분자 아형 위암 전 주기 진단 플랫폼 기술 개발연구책임자 : 강태준 / 사업기간 : 2025.01.01 ~ 2025.12.31 |
Research Project |
| 79 | 2024 | 2024Patent SYT11 억제제를 유효성분으로 포함하는 위암 치료용 조성물CN201980068374.8 (2021.04.16) / ZL201980068374.8 (2024.08.20)원미선; 김보경; 반현승; 박경찬; 염영일 |
Patent |
| 78 | 2024 | Patent | |
| 77 | 2024 | 2024Research Project 바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2024.01.01 ~ 2024.12.31 |
Research Project |
| 76 | 2024 | 2024Article CYB5R3 functions as a tumor suppressor by inducing ER stress-mediated apoptosis in lung cancer cells via the PERK-ATF4 and IRE1α-JNK pathwaysExperimental and Molecular Medicine, vol. 56, no. 1, pp. 235-249Joo-Young Im; S J Kim; Jong Lyul Park; Tae Hee Han; Woo-Il Kim; Inhyub Kim; Bomin Ko; So-Young Chun; Mi-Jung Kang; Bo Kyung Kim, et al. |
Article |
| 75 | 2024 | 2024Research Project 미만형 분자 아형 위암 전 주기 진단 플랫폼 기술 개발연구책임자 : 강태준 / 사업기간 : 2024.07.01 ~ 2024.12.31 |
Research Project |
| 74 | 2023 | 2023Patent DDIAS 억제제 및 사멸 수용체 리간드를 포함하는 암의 예방 또는 치료용 조성물KR10-2017-0115249 (2017.09.08) / 10-2532779 (2023.05.10)원미선; 임주영; 김보경; 반현승 |
Patent |
| 73 | 2023 | 2023Article TNF-α secreted from macrophages increases the expression of prometastatic integrin αV in gastric cancerInternational Journal of Molecular Sciences, vol. 24, no. 1, pp. 376-376Mi Aie Hwang; Misun Won; Joo-Young Im; Mi-Jung Kang; D H Kweon; Bo Kyung Kim |
Article |
| 72 | 2023 | 2023Research Project 바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2023.01.01 ~ 2023.12.31 |
Research Project |
| 71 | 2023 | 2023Article DDIAS, DNA damage-induced apoptosis suppressor, is a potential therapeutic target in cancerExperimental and Molecular Medicine, vol. 55, no. 5, pp. 879-885Joo-Young Im; Mi-Jung Kang; Bo Kyung Kim; Mi Sun Won |
Article |
| 70 | 2023 | 2023Research Project 암 치료 타겟 SYT11의 저해 물질 발굴연구책임자 : 김보경 / 사업기간 : 2023.06.01 ~ 2025.05.31 |
Research Project |
| 69 | 2022 | 2022Patent SYT11 억제제를 유효성분으로 포함하는 위암 치료용 조성물KR10-2019-0129281 (2019.10.17) / 10-2377702-0000 (2022.03.18)원미선; 김보경; 반현승; 박경찬; 염영일 |
Patent |
| 68 | 2022 | 2022Article Synaptotagmin 11 scaffolds MKK7-JNK signaling process to promote stem-like molecular subtype gastric cancer oncogenesisJournal of Experimental & Clinical Cancer Research, vol. 41, pp. 212-212Bo Kyung Kim; Da Mi Kim; Hyunkyung Park; Seon-Kyu Kim; Mi Aie Hwang; Jungwoon Lee; Mi-Jung Kang; Jae Eun Byun; Joo-Young Im; Minho Kang, et al. |
Article |
| 67 | 2022 | 2022Research Project 바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2022.01.01 ~ 2022.12.31 |
Research Project |
| 66 | 2022 | 2022Article DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor-resistant lung cancer therapyExperimental and Molecular Medicine, vol. 54, no. 8, pp. 1236-1249Haejeong Heo; Jong-Hwan Kim; Hyun Jung Lim; Jeong Hwan Kim; M Kim; J Koh; Joo-Young Im; Bo Kyung Kim; Mi Sun Won; Ji Hwan Park, et al. |
Article |
| 65 | 2022 | 2022Research Project 암대사를 조절하는 MDH1/2 이중 저해 항암물질 개발 = Development of anti-cancer drug MDH1/2 dual inhibitor controling cancer metabolism연구책임자 : 원미선 / 사업기간 : 2022.01.01 ~ 2023.06.30 |
Research Project |
| 64 | 2021 | Patent |